Transforming Sleep Apnea Care in America

Inhala is a MedTech company addressing one of America's most widespread yet poorly treated chronic conditions: Obstructive Sleep Apnea. With 40 million Americans affected and half of diagnosed patients abandoning CPAP within 12 months, the need for accessible alternatives has never been greater.

We've built the first scalable platform for custom oral appliance therapy, a proven CPAP alternative with 95% patient satisfaction, fully covered by Medicare and private insurance. By integrating dental and medical care, we're making effective sleep apnea treatment accessible to millions left behind by the current standard of care.

Our Approach

Inhala delivers a complete patient journey: At-home sleep testing, telemedicine diagnosis, 3D oral scanning, custom appliance fabrication, and payer reimbursement, all through our proprietary platform. 

We operate through strategically located scanning centers and leverage three proven channels: physician referrals, payer partnerships with Medicare and major PPOs, and direct-to-consumer marketing.

Proven Traction

Starting from 4 pilot locations in New York and North Carolina, we've treated 148 patients, generated $400K in validated revenue, and established credentialing with Medicare, Aetna, VA, and major commercial insurers. Our first year focused on refining our go-to-market playbook and de-risking expansion.

National Expansion

We're executing a disciplined rollout: 42 locations across the U.S. within 5 years, projecting $130M in annual revenue with 69% gross margins. Each mature location generates approximately $3.4M annually, serving 1,300 patients. We're currently raising a $3.4M Seed round to accelerate growth.

Our Mission

Make effective, comfortable sleep apnea treatment accessible to every American who needs it—no masks, no noise, just results.

Follow our journey from concept to national impact.

inhala

Org chart

Teams

Offices